BioSpace News Archive

Verisante Technology, Inc. is pleased to announce it has agreed to convert certain payables owed to Creditors into common shares in the capital of the Company.

A new prospective, multicenter study, recently published in The Lancet Neurology has revealed the significant prognostic value of the Neurological Pupil index™ (NPi®), measured using the NeurOptics NPi Pupillometer, in evaluating disease progression and predicting outcomes for patients with acute brain injury.

Co-Diagnostics, Inc. announced today that Co-Diagnostics will be presenting at the H.C. Wainwright & Co. 25th Annual Global Investment Conference, being held virtually and in-person on September 11-13 in New York City, New York.

Verily and Kyverna Therapeutics (“Kyverna”) today announced a multi-year collaboration to identify novel biomarkers and innovate clinical trial design and execution.

Viking Therapeutics, Inc. today announced that the company will participate at two upcoming investor conferences.

Hyperfine, Inc. today announced plans to participate at the upcoming Gilmartin Group Emerging Growth Showcase, taking place virtually.

Veracyte, Inc. (Nasdaq: VCYT) announced that Marie-Claire Taine, Ph.D., will join Veracyte as general manager of the company’s in vitro diagnostics (IVD) Business Unit, based in Marseille, France.

Lumos Pharma, Inc. announced that the Company will participate in the H.C. Wainwright 25th Annual Global Investment Conference being held September 11th – 13th.

Syros Pharmaceuticals today announced the grant of restricted stock unit (RSU) awards for an aggregate of 20,650 shares of Syros common stock to two newly hired employees in connection with commencing employment with Syros.

STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses for the eye, today announced that it will host an in-person Investor Day on Thursday, September 14, 2023, beginning at 8:00 a.m. Eastern Time in New York City.